- Home
- IBIO vs DXST Comparison
IBIO vs DXST Comparison
Compare IBIO & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- DXST
- Stock Information
- Founded
- IBIO 2008
- DXST 2011
- Country
- IBIO United States
- DXST China
- Employees
- IBIO N/A
- DXST N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- IBIO Health Care
- DXST
- Exchange
- IBIO Nasdaq
- DXST NYSE
- Market Cap
- IBIO 24.3M
- DXST 20.3M
- IPO Year
- IBIO N/A
- DXST 2025
- Fundamental
- Price
- IBIO $3.80
- DXST $1.31
- Analyst Decision
- IBIO Strong Buy
- DXST
- Analyst Count
- IBIO 3
- DXST 0
- Target Price
- IBIO $4.87
- DXST N/A
- AVG Volume (30 Days)
- IBIO 427.1K
- DXST 55.5K
- Earning Date
- IBIO 05-12-2025
- DXST 01-01-0001
- Dividend Yield
- IBIO N/A
- DXST N/A
- EPS Growth
- IBIO N/A
- DXST 13.11
- EPS
- IBIO N/A
- DXST 0.14
- Revenue
- IBIO $375,000.00
- DXST $11,542,292.00
- Revenue This Year
- IBIO $36.00
- DXST N/A
- Revenue Next Year
- IBIO $33.33
- DXST N/A
- P/E Ratio
- IBIO N/A
- DXST $9.48
- Revenue Growth
- IBIO 650.00
- DXST 22.18
- 52 Week Low
- IBIO $1.50
- DXST $0.86
- 52 Week High
- IBIO $6.89
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- IBIO 38.87
- DXST N/A
- Support Level
- IBIO $3.80
- DXST N/A
- Resistance Level
- IBIO $4.23
- DXST N/A
- Average True Range (ATR)
- IBIO 0.44
- DXST 0.00
- MACD
- IBIO -0.15
- DXST 0.00
- Stochastic Oscillator
- IBIO 6.21
- DXST 0.00
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.